Renin-Angiotensin-Aldosterone Inhibitors and COVID-19

被引：0
|
作者：
Benenson, Irina [1 ]
Waldron, Frederick [2 ]
机构：
[1] Rutgers State Univ, Sch Nursing, Newark, NJ 07102 USA
[2] Newark Beth Israel Med Ctr, Dept Emergency Med, Newark, NJ USA
来源：
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2020年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.nurpra.2020.05.007
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
[No abstract available]
引用
收藏
页码：545 / 546
页数：2
相关论文
共 50 条
  • [21] Renin-Angiotensin-Aldosterone System Inhibitors and the Risk of AKI in COVID-19 Compared with Influenza
    Birkelo, Bethany C.
    Parr, Sharidan K.
    Perkins, Amy M.
    Greevy Jr, Robert A. A.
    Arroyo, Juan Pablo
    Hung, Adriana M.
    Vincz, Andrew J.
    Shah, Shailja C.
    Kapoor, Tarun
    Matheny, Michael E.
    Siew, Edward D.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (03): : 423 - 425
  • [22] Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors and Coronavirus Disease 2019 (COVID-19)
    Albashir, Ahmed Abdalazim Dafallah
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (01) : 51 - 56
  • [23] Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection or Hospitalization: A Cohort Study
    Dublin, Sascha
    Walker, Rod L.
    Floyd, James S.
    Shortreed, Susan M.
    Fuller, Sharon
    Albertson-Junkans, Ladia
    Harrington, Laura B.
    Greenwood-Hickman, Mikael Anne
    Green, Beverly B.
    Psaty, Bruce M.
    AMERICAN JOURNAL OF HYPERTENSION, 2021, 34 (04) : 339 - 347
  • [24] Inhibitors of the renin-angiotensin-aldosterone system and COVID-19 in critically ill elderly patients
    Jung, Christian
    Bruno, Raphael Romano
    Wernly, Bernhard
    Joannidis, Michael
    Oeyen, Sandra
    Zafeiridis, Tilemachos
    Marsh, Brian
    Andersen, Finn H.
    Moreno, Rui
    Fernandes, Ana Margarida
    Artigas, Antonio
    Pinto, Bernardo Bollen
    Schefold, Joerg
    Wolff, Georg
    Kelm, Malte
    De Lange, Dylan W.
    Guidet, Bertrand
    Flaatten, Hans
    Fjolner, Jesper
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (01) : 76 - 77
  • [25] The renin-angiotensin-aldosterone system inhibitors in COVID-19: from acidosis to ventilation and immunity
    Wan-Hui, Liao
    Gee-Gwo, Yang
    Maciej, Henneberg
    SWISS MEDICAL WEEKLY, 2020, 150 : w20444
  • [26] Risk of Covid-19 with renin-angiotensin-aldosterone system medications
    Reactions Weekly, 2020, 1804 (1) : 11 - 11
  • [27] Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity
    Goncalves, Jorge
    Santos, Catarina D.
    Fresco, Paula
    Fernandez-Llimos, Fernando
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2023, 42 (04) : 373 - 383
  • [28] Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
    Mancia, Giuseppe
    Rea, Federico
    Ludergnani, Monica
    Apolone, Giovanni
    Corrao, Giovanni
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25): : 2431 - 2440
  • [29] Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19
    Sarzani, Riccardo
    Giulietti, Federico
    Di Pentima, Chiara
    Filipponi, Andrea
    Spannella, Francesco
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (05) : 885 - 887
  • [30] Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19
    Williams, Bryan
    Zhang, Yi
    LANCET, 2020, 395 (10238): : 1671 - 1673
12345